NPI: 1285990168 · KANSAS CITY, MO 64130 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/05/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/05/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,455 | $179K |
| 2019 | 9,859 | $240K |
| 2020 | 11,683 | $248K |
| 2021 | 5,126 | $210K |
| 2022 | 6,398 | $235K |
| 2023 | 4,599 | $140K |
| 2024 | 3,302 | $180K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,692 | 2,444 | $1.43M |
| J3490 | Unclassified drugs | 1,385 | 80 | $138.78 |
| 83550 | 564 | 470 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,456 | 485 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,668 | 322 | $0.00 |
| 82728 | 558 | 465 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 616 | 545 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 35 | 30 | $0.00 |
| 85048 | 552 | 447 | $0.00 | |
| 85041 | 552 | 446 | $0.00 | |
| 83540 | 562 | 470 | $0.00 | |
| 83970 | 333 | 271 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 360 | 76 | $0.00 |
| 82652 | 30 | 29 | $0.00 | |
| 82108 | 47 | 42 | $0.00 |